Therapeutic potential of an intestinotrophic hormone, glucagon-like peptide 2, for treatment of type 2 short bowel syndrome rats with intestinal bacterial and fungal dysbiosis

BACKGROUND: Previous studies showed that type 2 short bowel syndrome (SBS) rats were accompanied by severe intestinal bacterial dysbiosis. Limited data are available for intestinal fungal dysbiosis. Moreover, no effective therapeutic drugs are available for these microbiota dysbiosis. The aims of ou...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Xiuting, Cheng, Wei, Fan, Shengxian, Huang, Yuhua, Chen, Xi, Jiang, Zhiwei, Wang, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8207711/
https://www.ncbi.nlm.nih.gov/pubmed/34134659
http://dx.doi.org/10.1186/s12879-021-06270-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8207711/
https://www.ncbi.nlm.nih.gov/pubmed/34134659
http://dx.doi.org/10.1186/s12879-021-06270-w

Ejemplares similares